Diabetes conferences | Endocrinology Conferences|Global Meetings| Birmingham| UK| Europe | USA | 2016

Theme: New approaches in Diabetes care and Prevention

Diabetes Global 2016

Scientific program (2016)

Renowned Speakers

Michael Yafi
The University of Texas Medical School at Houston
USA

Omo Ojo
University of Greenwich
UK

Belma Turan
Ankara University
Turkey

Lixin Li
Central Michigan University
USA

Rachel Knott
Robert Gordon University
UK

Douglas Ishii
Colorado State University
USA

Diabetes Global 2016

Track 1: Anatomy and physiology of diabetes

Pathophysiologic modification is a change in task as notable from a structural defect. Diabetes occurs when there is a dis-balance between the demand and manufacture of the hormone insulin. Pathophysiology of diabetes is that in this circumstance the immune system outbreaks and terminates the beta cells of the pancreas which produce insulin. There is lack of beta cell leading to complete insulin deficiency. Whereas in type 2 diabetes there is comparatively lesser deficiency of insulin and not an complete deficiency. This means that the body is incapable to harvest appropriate insulin to overcome the demand. There is Beta cell deficiency coupled with peripheral insulin resistance. Gestational diabetes is the third type of diabetes. It is caused when there are excessive counter-insulin hormones of pregnancy. This paves the way to a state of insulin resistance and high blood sugar in the mother. There may be faulty insulin receptors. These part of diabetes study is covered in ADA meetings and IDF word Diabetes Congress

11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; 9th Global Diabetologists Annual Meeting and Medicare Expo June 06-08 2016, USA;8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 7th Indo Global Diabetes Summit and Medicare Expo November 23-25, 2015,India; Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Canada; 18th International Conference on Diabetes and Immunology May 23-24 2016, UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Canada; ISN World Congress of Nephrology April 21-25 2017, Mexico, Endocrinology Conferences October 10-12, 2016 Manchester, UK

Track 2: Clinical and diagnostic approaches

Diabetes may be analysed based on both plasma glucose criteria or A1C criteria. Early in disease diabetes shows no symptoms so blood tests are used to diagnose diabetes and pre-diabetes. Clinical diagnostic in diabetes involve taking blood at a healthcare facility centre or commercial diagnostic centre and sending the sample to a lab for examination. To ensure that test results are accurate lab study of blood of required. Glucose calculating devices used in a health care provider’s office, such as finger-stick devices, are not precise enough for analysis but may be used as a rapid indicator of high blood sugar. Such area of research are highle discussed in ADA annual meeting and ADA sessions

Diabetes Conferences, September 29- October 01, Berlin, Germany, Canada;11th Asia Pacific, Diabetes Conference and Expo July 11-13 2016,Australia; 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE; 15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; The 5th World Congress on Controversies to Consensus in Diabetes, Hypertension and Obesity November 05-07, 2015,Turkey; 43rd Meeting of the British Society for Paediatric Endocrinology and Diabetes November 25-27 2015, UK; , European Association for the Study of Diabetes Eye Complications Study Group 26th Annual Meeting June 16-18 2016, UK; International Conference on Metabolic Syndromes October 20-22, 2016,UAE, Obesity Medical Conferences Nov 14-15, 2016 Dubai, UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK

Track 3: Diabetes Case Studies

Diabetes case reports are in-depth inquiries of an individual, crowd, occasion or public. The data are assembled from a diversity of places by various methods.The case study technique encompasses spotting what happens to, or reconstructing ‘the case history’ of a single participant or group of individuals, i.e the idiographic approach. Case studies permits an investigator to investigate a topic in far more detailed and minute way.The case study is not itself a research method, but investigators choose methods of data collection and analysis that will generate material suitable for case studies. Most of this evidence is likely to be qualitative but the psychologist might collect numerical data as well and present in various diabetes conference and scientific sessions

Diabetes Conferences, September 15- September 17, Berlin, Germany, 9th Global Diabetologists Annual Meeting and Medicare Expo June 06-08 2016,USA ; 11th Asia Pacific Diabetes Conference and Expo July 11-13 2016,Australia; 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE;15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE;11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016, Malaysia; Mid-Atlantic AACE 13th Annual meeting on Endocrinology Sep 25-26 2015, USA; AACE New England annual meeting on endocrinology November 14th 2015, Marlborough; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Endocrinology Conferences October 10-12, 2016 Manchester, UK, Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Track 4: Symptoms, prevention and treatment of diabetes

Diabetes is a severe illness that cannot be cured of its own. Doctor aids to create a diabetes management plan that is right for the patient. Cure for diabetes demands to keep close watch over the blood sugar level with a combination of medications, work out, and diet. Since the spectacular finding in Toronto in 1922 that type 1 diabetes arises from a deficit of insulin. Research on Insulin is extensively discussed in National Diabetes Conference and Diabetes associations.The supervision of diabetes has been decisively grounded in scientific advances that endure to outline our understanding of the pathophysiology of diabetes and direct our choices in choosing optimal therapies for type 1 and type 2 diabetes. Now, a days we get in market glucose meters which is a modern technology which has the capability to help people living with type 1 or type 2 diabetes and treated with insulin to accomplish the dream of ideal control of blood sugar.

Diabetes Conferences, September 15- September 17, Berlin, Germany, 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE; 15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 9th Global Diabetologists Annual Meeting and Medicare Expo June 06-08 2016, USA; Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; New Therapeutics for Diabetes and Obesity April 17-20, 2016 USA; International Conference on Diabetes Mellitus September 18-20 2015, China; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016; ; International Conference on Metabolic Syndromes October 20-22, 2016,UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK, Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 5: Diabetes in Market

Diabetes trade directs to the 11 largest therapeutic and diagnostic companies producing diabetes related merchandises or those involved with to take diabetes cure to next level. Diabetes is a major issue in the UK, and as such a large healthcare and medical industry has come up like mushroom around it. Aspects such as growing number of diabetic patients across BRIC countries, increasing study on diabetes, and increasing international research collaborations are lashing the growth of the this market. In the European Region there is about 60 million people leaving with diabetes, or about 10.3% of men and 9.6% of women aged 25 years and over. Occurrence of diabetes is growing among all ages in the, typically due to escalations in overweight and obesity, unhealthy diet and less of physical activity.

Track 6: Complementary and Alternative Medicine and Therapies

Complementary and alternative medicine is can be well-defined as a "cluster of varied therapeutic and health care arrangements, practices, and medicines that are not presently measured to be part of predictable medicine”. Complementary medicine is used with predictable therapy, whereas alternative medicine is used instead of conventional medicine. In CAM therapies diabetes supplement is widely given to the diabetic patients in. Although some of these therapies may be useful, others can be not so useful or even harmful. Contrary reactions of many CAM therapies are not well known because patients with diabetes often take various diabetes medications, there occurs budding for herbal medicine and herb dietary habit supplement interactions, leading to contrary events.

Track 7: Biomarker: Diagnostic tool for Diabetes

Molecular Biomarkers can be demarcated as “a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacologic responses to a pharmaceutical intervention. Biomarkers play an vital part in leading clinical trials and treating patients. Advances in molecular diagnostics help medical professionals make knowledgeable, scientifically valid decisions. More well-organized discovery and usage of biomarkers in the growth of antidiabetes drugs will depend on accelerating our understanding of the pathogenesis of diabetes and specifically its macrovascular complications. Procedural improvements from other fields, especially cancer, are beginning to show the way towards better models of diabetes pathogenesis and molecular biomarker discovery.

Track 8: Endocrinology: Disorder and Treatment

Clinical Endocrinology and metabolism is a field of medicine; more precisely a sub-specialty of internal medicine, which mainly deals with the investigation and management of sicknesses related to hormones. The human endocrine system involves number of glands. These glands harvest and release hormones which monitors many important function of our body. When the hormones exits the glands they arrive the bloodstream and are moved to organs and tissues in every part of the body. Endocrinology also concentrates on the endocrine glands and tissues that secrete hormones. The human endocrine system comprises of several glands. These glands harvest and secrete hormones which regulates the body's metabolism, growth, sexual development and function. Hormonal imbalance in our body henceforth leads to diabetes.

Track 9: Diabetes and its Complications

Long-standing complications of diabetes grow progressively. Number of years of having diabetes is directly proportional to the higher risk of complications. Sometimes diabetes complications may be restricting or even lethal. A well-controlled blood sugar have less diabetic complications. Broader health issues quicken the venomous effects of diabetes which include smoking, higher diabetes cholesterol levels, obesity, high blood pressure, and lack of regular exercise. The best forecaster of type 2 diabetes is overweight or obesity. People who have weight related issues or have obesity have additional pressure on their body's capability to use insulin to properly control blood sugar levels, and are therefore pick up diabetes more easily.

Track 10: Diabetes and Associated Diseases

Diabetes intensifies the danger of long-term complications. Diabetes increases the risk of cardiovascular diseases such as diabetic cardiomyopathy. The chief complications of diabetes due to injury in small blood vessels comprise damage to the eyes, kidneys, and nerves. Damage to the eyes is known as diabetic retinopathy which is triggered by damage to the blood vessels in the retina of the eye leading to diabetic eye complications. Damage to the kidneys, known as diabetic nephropathy, can pave the way to tissue damaging, urine protein damage, and eventually dibetic nephropathy disease. Diabetes is one of the main cause of kidney failure. At least two third of the people with diabetes may have signs of onset of kidney problems at early stage. Damage to the nerves of the body, known as diabetic neuropathy, is the most common complication of diabetes.

Track 11: Genetics and Transplantation of Diabetes

Metabolic syndrome and related metabolic traits heritability is relatively high. Genetically altered knockout mice models and human monogenic obese/insulin unaffected syndrome deliver significant molecular insights into the pathogenesis of the metabolic syndrome. Transfer (engraftment) of human cells, tissues or organs from a donor to a recipient with the aim of restoring function in the body is called as transplantation. It can be of various types such as pancreas transplantation, xenotransplantation and islet transplantation.

Track 12: T herapy for Diabetes and its Complications

Cell therapy can be explained as the supervision of live whole cells or maturation of an exact cell population in a patient to overcome the disease. Cell therapy is growing its range of cell types for administration. The treatment strategies of cell therapy comprise separation and transmission of specific stem cell populations, administration of effector cells, induction of mature cells to develop pluripotent cells, and reprogramming of mature cells. The founding of pluripotent human embryonic stem cells and embryonic germ cells have presented a new probable source in type 1 diabetic patients for cell therapy, especially in light of recent successes in generating glucose-sensitive insulin-secreting cells from mouse embryonic stem cells.

Track 13: Market analysis of Diabetic products

Diabetes care market encompasses of technologies, devices and therapeutics in relative to diabetes. There has been a substantial increase in the amount of diabetes cases internationally over the last few years. Currently, about millions of people are in misery because of obesity, which is a key reason for increase of diabetes in people. Key Players profiled in the report include Glaxosmithkline, Novo Nordisk, Roche, Medtronicand etc. Novo Nordisk is a leading global provider of diabetes products. The company also has a headship spot in hemostasis management, growth hormone therapy and hormone replacement therapy. The company progresses, manufactures and markets its medical devices and technologies to hospitals, doctors, researchers, scientists and patients in approximately 160 countries.

Track 14: Emerging Focus in Diabetes Research

Diabetes throws a light in a growing epidemic imposing thoughtful social economic crisis around the nation. Despite scientific innovations and better healthcare research amenities the disease continues to burden numerous segments, especially middle and low income countries. The current trends designate the rise in premature death, posing a major threat to global development. The advancement in science and technology have observed the expansion of newer generation of nanomedicine in drugs discovery. Then, the documentation and clinical investigation of bioactive ingredients from plants have transformed the investigation on drug discovery and lead identification for diabetes management control.

Omics International Conference appeals all the participants from all around the nation to attend '13th Global Diabetes and Medicare Expo' which is going to be held in August 08-10, 2016 at Birmingham, UK which includes highly expertise key note panel, oral and poster presentation and exhibitions by the leading companies of diabetes

Diabetes Global 2016 is devoted to “New approaches in Diabetes care and prevention”. Diabetes is globally familiar as one of the foremost causes of death and incapacity in the United States. In 2000, it was the sixth chief cause of death. About 65% of deaths within people living with diabetes are attributed to stroke and heart disease. Diabetes is related with long-term complications that affect almost each and every part of the body. Unrestricted diabetes can confuse pregnancy, and birth flaws are more common in babies born to women with diabetes.

Scope and Importance of Diabetes

Diabetes is globally familiar as one of the foremost causes of death and incapacity in the United States. In 2000, it was the sixth chief cause of death. About 65% of deaths within people living with diabetes are attributed to stroke and heart disease. Diabetes is related with long-term complications that affect almost each and every part of the body. Unrestricted diabetes can confuse pregnancy, and birth flaws are more common in babies born to women with diabetes. The task of the International Diabetes Federation is to encourage diabetes care, prevention and a cure worldwide. Clinical trials are an vital step in our being able to have new treatments for diabetes and other conditions.

Why Birmingham (UK)?

The number of people diagnosed with diabetes in the UK has increased to more than 3.2 million, according to figures released by Diabetes UK. The new figures demonstrate that the sharp rise in people with diabetes seen in the UK over the last decade shows no sign of decelerating down. New figures show that Birmingham has the maximum rate of diabetes in the country, with nearly one in 10 people in some parts of the UK's second largest city living with disease.

Societies associated with diabetes research

To inspire, educate, apprise and train registered medical practitioners, dieticians, qualified nurses and other appropriately qualified paramedical personnel in the field of Diabetes various well-known societies/associations are working across the world to professionally avoid and combat the lethal disease

Major diabetes association in UK:

· British Diabetic association

· Diabetes UK

· Association of British Clinical Diabetologists

· British Society for Paediatric Endocrinology and Diabetes

Major diabetes association in Europe:

· European association for the study of diabetes

· European diabetes foundation

· Diabetes Association Switzerland

· Spanish Diabetes Society (Spain)

· Swedish Diabetes Association

Major diabetes association in USA:

· American Diabetes Association

· American Association of Clinical Endocrinologists

· Centre for Disease Control: Division of Diabetes Translation

· Diabetes Advocacy Alliance

· Diabetes Hands Foundation

· Juvenile Diabetes Foundation International

· National Kidney Foundation

· National Institute of Diabetes and Digestive and Kidney Diseases

Major Diabetes Associations around the Globe:

· Diabetes Indian Association

· Canadian Diabetes Association

· International Diabetes Federation

· Diabetes Australia

· Austrian Diabetes Association.

· Diabetes South Africa

· Asia diabetes foundation

· Asian association for the study of diabetes

· Korean Diabetes Association

Market research on diabetes

Diabetes industry guides to the 11 largest pharmaceutical and diagnostic companies producing diabetes related products or those involved with diabetes research. Diabetes is a major problem in the UK, and as such a large healthcare and treatment industry has built up around it.Diabetes care devices market is estimated to grow at a CAGR of 6.3% from 2015 to 2020, to reach USD 2.3 Billion by 2020 from USD 1.7 Billion in 2015. Factors such as increasing number of diabetic patients across BRIC countries, growing research on diabetes, and increasing international research collaborations are driving the growth of the this market. Rising obese population and lifestyle changes (driving the prevalence of diabetes among the urban population) are further contributing to the growth of this market. However, high cost of diabetes care devices, disparity in reimbursement, availability of alternative treatments, and lack of awareness are restraining the growth of this market.

Global prevalence of diabetes

One in 10 people globally will have diabetes by 2035, according to a concerning new report.To highlight World Diabetes Day which takes place each year on Nov. 14, the International Diabetes Federation (IDF) released its sixth edition of the Diabetes Atlas. The report estimates how many adults between the ages of 20 to 79 will be affected by the disease in the future. By the end of this year, the IDF estimates that 382 million people will have diabetes around the world. By 2035, that number will skyrocket to 592 million. For comparison, about 285 million people had the disease just four years ago. Eighty percent of people with the disease live in low- and middle-income countries, and most of them are between 40 and 59 years old. The organization also said that one person dies from diabetes every six seconds, or about 5.1 million deaths annually.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	August 08-10, 2016
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2	Day 3
Poster Opportunity Closed	Click Here to View

Media Partners

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

13^thGlobal Diabetes Conference & Medicare Expo August 08-10, 2016 Birmingham, UK

Recommended Global Diabetes & Endocrinology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links